Clinical Trial Update: Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of WC3011 (Estradiol Vaginal Cream) for postmenopausal vulvovaginal atrophy; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Vulvar and Vaginal Atrophy
• Vulvovaginal Atrophy

Drugs mentioned

• WC3011 (estradiol vaginal cream)

Snippet

Sponsor: Warner Chilcott | Conditions: Postmenopausal Vulvovaginal Atrophy | Phase 3 | Status: COMPLETED | Results posted: 2022-05-09